Patents by Inventor John E. Lallaman

John E. Lallaman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200325506
    Abstract: Disclosed herein is a process for preparing enantioenriched (S)-2-aminonon-8-enoic acid by amination of 2-oxonon-8-enoic acid in the presence of an enzyme and an ammonia source.
    Type: Application
    Filed: November 4, 2019
    Publication date: October 15, 2020
    Inventors: Michael J. Abrahamson, Julie J. Pruyne, Angelica B. Kielbus, John E. Lallaman, Rajarathnam E. Reddy, Sanjay R. Chemburkar
  • Patent number: 10465216
    Abstract: Disclosed herein is a process for preparing enantioenriched (S)-2-aminonon-8-enoic acid by amination of 2-oxonon-8-enoic acid in the presence of an enzyme and an ammonia source.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: November 5, 2019
    Assignee: AbbVie Inc.
    Inventors: Michael J. Abrahamson, Julie J. Pruyne, Angelica B. Kielbus, John E. Lallaman, Rajarathnam E. Reddy, Sanjay R. Chemburkar
  • Publication number: 20190048372
    Abstract: Disclosed herein is a process for preparing enantioenriched (S)-2-aminonon-8-enoic acid by amination of 2-oxonon-8-enoic acid in the presence of an enzyme and an ammonia source.
    Type: Application
    Filed: August 27, 2018
    Publication date: February 14, 2019
    Inventors: Michael J. Abrahamson, Julie J. Pruyne, Angelica B. Kielbus, John E. Lallaman, Rajarathnam E. Reddy, Sanjay R. Chemburkar
  • Patent number: 10059969
    Abstract: Disclosed herein is a process for preparing enantioenriched (S)-2-aminonon-8-enoic acid by amination of 2-oxonon-8-enoic acid in the presence of an enzyme and an ammonia source.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: August 28, 2018
    Assignee: AbbVie Inc.
    Inventors: Michael J. Abrahamson, Julie J. Pruyne, Angelica B. Kielbus, John E. Lallaman, Rajarathnam E. Reddy, Sanjay R. Chemburkar
  • Patent number: 6605707
    Abstract: Disclosed herein is a process for the preparation of erythromycin derivatives, or pharmaceutically acceptable salts thereof, which contain an optionally substituted propargyl group at the 6-O-position.
    Type: Grant
    Filed: March 23, 2000
    Date of Patent: August 12, 2003
    Assignee: Abbott Laboratories
    Inventors: Francis A. J. Kerdesky, Ramiya Premchandran, Gregory S. Wayne, Sou-Jen Chang, Jonathan P. Pease, Lakshmi Bhagavatula, John E. Lallaman, Howard E. Morton, Steven A. King
  • Patent number: 6160122
    Abstract: A process is disclosed for the preparation of N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)-amino acid derivatives.
    Type: Grant
    Filed: June 28, 1996
    Date of Patent: December 12, 2000
    Assignee: Abbott Laboratories
    Inventors: Patricia A. Oliver, Arthur J. Cooper, John E. Lallaman, Denton C. Langridge, Jieh-Heh J. Tien
  • Patent number: 6124474
    Abstract: A process for preparing chiral isomers of N-protected 2-azetidinemethanol compounds, particularly N-(phenylmethyl)-2-azetidinemethanol and N-BOC-2-azetidinemethanol, and especially the (R)-isomers thereof, as well as O-substituted derivatives thereof.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: September 26, 2000
    Assignee: Abbott Laboratories
    Inventors: Anthony R. Haight, John E. Lallaman, Gregory S. Wayne